http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-PI0715929-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_01334e145ec0480e41a4cabb40e153bb |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-343 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-343 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24 |
| filingDate | 2007-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c4d15a0e3201145f4d3de001902f0cb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aaca07abe244baebd787ca016dc387b1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d63567aca3775c9fc8ee91d2f6f94a07 |
| publicationDate | 2013-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | BR-PI0715929-A2 |
| titleOfInvention | ligustilide derivatives for the treatment of central nervous system disorders |
| abstract | LIGUSTILIDE DERIVATIVES FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS. The present invention relates to compounds of formula wherein R 1 is hydrogen or hydroxy; R2 is butyl or butyryl if R1 is hydroxy, but R2 is butyl if R1 is hydrogen; or R 1 and R 2 taken together are 1 propylidene or 1 butylidene optionally substituted by hy-droxy, by dimethylacryloyloxy); the dotted line is a beta, alpha-methyl bond, or 3 (optional; X is optionally substituted C4- aliphatic residue selected from the group X1, X2, X3, X4 and X5 constituting; where X and X2, X3 or X5 is the dotted line of the formula (I) is absent, and X is X1, X4 or X5 if the dotted line means a bond in the above formula (I), R3 and R4 are independent of whether hydrogen or hydroxy, R5 is hydroxy or butyryl to use in the treatment of disorders has connected to impaired neurotransmission, as well as pharmaceutical dietary compositions containing such compounds, and their uses. |
| priorityDate | 2006-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 184.